Neuren Pharmaceuticals (NURPF) Short Interest Ratio & Short Volume C$8.45 0.00 (0.00%) (As of 11/7/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartHeadlinesShort Interest Neuren Pharmaceuticals Short Interest DataNeuren Pharmaceuticals (NURPF) has a short interest of 1.94 million shares. This marks a -1.94% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2,429.5, indicating that it would take 2,429.5 days of the average trading volume of 3,219 shares to cover all short positions.Current Short Interest1,943,600 sharesPrevious Short Interest1,982,100 sharesChange Vs. Previous Month-1.94%Dollar Volume Sold Short$12.85 millionShort Interest Ratio2,429.5 Days to CoverLast Record DateOctober 15, 2024Today's Trading Volume0 sharesAverage Trading Volume3,219 sharesToday's Volume Vs. Average0% Short Selling Neuren Pharmaceuticals? Sign up to receive the latest short interest report for Neuren Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNURPF Short Interest Over TimeNURPF Days to Cover Over TimeNURPF Percentage of Float Shorted Over Time Ad Colonial MetalsTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…Get Your Free Gold Guide Neuren Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/20241,943,600 shares C$12.85 million -1.9%N/A2429.5 $6.61 9/30/20241,982,100 shares C$20.48 million -0.5%N/A19821 $10.33 9/15/20241,992,800 shares C$18.49 million +0.3%N/A2846.9 $9.28 8/31/20241,987,900 shares C$20.28 million -0.4%N/A1987.9 $10.20 8/15/20241,996,300 shares C$21.96 million +17.4%N/A570.4 $11.00 7/31/20241,700,300 shares C$24.23 million +0.2%N/A17003 $14.25 Get the Latest News and Ratings for NURPF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neuren Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/15/20241,697,200 shares C$24.19 million +2.4%N/A16972 $14.25 6/30/20241,657,900 shares C$23.63 million +2.9%N/A1657.9 $14.25 6/15/20241,610,900 shares C$20.30 million +0.6%N/A8054.5 $12.60 5/31/20241,601,800 shares C$21.62 million +2.7%N/A1232.2 $13.50 5/15/20241,559,200 shares C$21.14 million +12.9%N/A5197.3 $13.56 4/30/20241,380,500 shares C$17.27 million +16.6%N/A6902.5 $12.51 4/15/20241,184,100 shares C$14.84 million -0.2%N/A2960.3 $12.53 3/31/20241,187,000 shares C$15.97 million +0.3%N/A11870 $13.45 3/15/20241,183,900 shares C$16.57 million +0.1%N/A5919.5 $14.00 2/29/20241,183,000 shares C$14.20 million +0.4%N/A514.3 $12.00 2/15/20241,178,500 shares C$17.51 million +25.2%N/A41.8 $14.86 1/15/2024496,400 shares C$7.68 million +4,036.7%N/A551.6 $15.47 12/31/202312,000 shares C$203,760.00 +36.4%N/A9.4 $16.98 12/15/20238,800 shares C$97,328.00 -6.4%N/A4.9 $11.06 11/30/20239,400 shares C$93,718.00 -7.8%N/A23.5 $9.97 11/15/202310,200 shares C$91,800.00 -1.0%N/A4.6 $9.00 10/31/202310,300 shares C$67,980.00 +2.0%N/A11.4 $6.60 10/15/202310,100 shares C$73,730.00 No ChangeN/A14.4 $7.30 9/30/202310,100 shares C$74,336.00 -44.8%N/A1.2 $7.36 9/15/202318,300 shares C$134,871.00 -39.2%N/A45.8 $7.37 8/31/202330,100 shares C$254,194.50 -17.1%N/A1.3 $8.45 8/15/202336,300 shares C$286,407.00 -0.8%N/A9.6 $7.89 7/31/202336,600 shares C$350,262.00 +2.8%N/A91.5 $9.57 7/15/202335,600 shares C$327,520.00 +3,136.4%N/A178 $9.20 6/30/20231,100 shares C$8,800.00 -50.0%N/A2.2 $8.00 6/15/20232,200 shares C$19,492.00 +214.3%N/A0.8 $8.86 5/31/2023700 shares C$6,195.00 +250.0%N/A7 $8.85 5/15/2023200 shares C$1,850.00 No ChangeN/A2 $9.25 4/30/2023200 shares C$1,886.00 -33.3%N/A0.5 $9.43 4/15/2023300 shares C$2,682.00 +200.0%N/A1.5 $8.94 3/31/2023100 shares C$911.79 -95.2%N/A0 $9.12 3/15/20232,100 shares C$16,390.50 -66.7%N/A1.1 $7.81 2/28/20236,300 shares C$30,366.00 +215.0%N/A0.4 $4.82 2/15/20232,000 shares C$9,960.20 +150.0%N/A1.3 $4.98The centerpiece of Trump’s crypto’s masterplan … (Ad)Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin conference in Nashville … Where he told an adoring crowd that the U.S. would become … “The crypto capital of the planet and the Bitcoin superpower of the world.”Click here to find out more about what could be Trump and JD Vance’s favorite coin. 1/31/2023800 shares C$4,392.00 +300.0%N/A0.2 $5.49 1/15/2023200 shares C$1,227.00 No ChangeN/A2 $6.14 12/30/2022200 shares C$1,090.00 -50.0%N/A0 $5.45 12/15/2022400 shares C$1,966.00 -89.2%N/A0.5 $4.92 11/30/20223,700 shares C$20,331.50 +15.6%N/A7.4 $5.50 11/15/20223,200 shares C$18,016.00 +14.3%N/A6.4 $5.63 10/31/20222,800 shares C$13,440.00 -3.5%N/A0.1 $4.80 10/15/20222,900 shares C$12,035.00 -9.4%N/A9.7 $4.15 9/30/20223,200 shares C$13,696.00 +45.5%N/A5.3 $4.28 9/15/20222,200 shares C$9,900.00 +266.7%N/A0.1 $4.50 8/31/2022600 shares C$2,472.00 -73.9%N/A0.8 $4.12 8/15/20222,300 shares C$9,200.00 No ChangeN/A0.2 $4.00 6/30/2022400 shares C$1,040.00 -86.7%N/A4 $2.60 6/15/20223,000 shares C$0.00 +25.0%N/A30 $0.00 NURPF Short Interest - Frequently Asked Questions What is Neuren Pharmaceuticals' current short interest? Short interest is the volume of Neuren Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 15th, traders have sold 1,943,600 shares of NURPF short. Learn More on Neuren Pharmaceuticals' current short interest. What is a good short interest ratio for Neuren Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NURPF shares currently have a short interest ratio of 2,430.0. Learn More on Neuren Pharmaceuticals's short interest ratio. Is Neuren Pharmaceuticals' short interest increasing or decreasing? Neuren Pharmaceuticals saw a decrease in short interest in the month of October. As of October 15th, there was short interest totaling 1,943,600 shares, a decrease of 1.9% from the previous total of 1,982,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Neuren Pharmaceuticals stock? Short selling NURPF is an investing strategy that aims to generate trading profit from Neuren Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Neuren Pharmaceuticals? A short squeeze for Neuren Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NURPF, which in turn drives the price of the stock up even further. How often is Neuren Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NURPF, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies ATNFW Short Interest TRSBF Short Interest AGNPF Short Interest DRTSW Short Interest WENAW Short Interest APLMW Short Interest ASPHF Short Interest ASCLF Short Interest AVCTF Short Interest AWKNF Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:NURPF) was last updated on 11/8/2024 by MarketBeat.com Staff From Our PartnersThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump’s Victory Just Kicked the Door Open to a…This story is about a division that has been splitting America apart at the seams for the past three and a hal...Banyan Hill Publishing | SponsoredThis Hidden Threat Could Destroy Your RetirementEvery day you wait, your savings are at greater risk. The government isn't slowing down, inflation isn't stopp...Golden Crest | SponsoredAI Stocks Are Poised to Explode Under TrumpDonald Trump's return to the White House has set the stage for an unprecedented market opportunity. His pro-bu...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neuren Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Neuren Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.